SCHEMBL24329206

SCHEMBL24329206

O=C1NC(O)CCC1N1Oc2ccc(Br)c3cccc1c23

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 5/20 0.33
CDK5 Q00535 1/20 0.30
CDK5R1 Q15078 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24317593 0.81 CRBN (0.44)
SCHEMBL24317401 0.64 CRBN (0.46)
SCHEMBL24317383 0.62 CRBN (0.46)
SCHEMBL29532547 0.61 CRBN (0.46)
SCHEMBL24317403 0.61 CRBN (0.46)
SCHEMBL24830140 0.61 CRBN (0.50) CDK5
SCHEMBL24663570 0.61 MAPT (0.45) CYP1B1
SCHEMBL24592089 0.60 CRBN (0.55)
SCHEMBL24779909 0.60 DDB1 (0.43)
SCHEMBL19526040 0.59 DDB1 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081928-A1 TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED PROTEINS C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed